WST Stock Analysis: Buy, Sell, or Hold?
WST - West Pharmaceutical Services, Inc.
$340.96
1.37 (0.40%)
▲
5d:
+3.89%
30d:
-6.59%
90d:
+14.57%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Oct 22, 2026
Get Alerted When WST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: WST shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: WST shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$357.85
Based on 7.6% avg growth
INTRINSIC VALUE TODAY
$222.20
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: WST is currently trading at $340.96, which is considered oversold relative to its 30-day fair value range of $340.04 to $362.80. The stock's valuation (Forward PE: 34.3) is in line with its historical norms (32.4). At these levels, the market is pricing in 1.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, WST is in a strong uptrend. Immediate support is located at $325.27, while resistance sits at $386.00.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $403.93 (+18.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, WST is in a strong uptrend. Immediate support is located at $325.27, while resistance sits at $386.00.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $403.93 (+18.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$340.04 -
$362.80
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($403.93)
- NEUTRAL: Market pricing in 1.9% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$340.04 -
$362.80
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$325.27
Resistance Level
$386.00
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
34.31
Wall Street Target
$403.93
(+18.5%)
Revenue Growth (YoY)
13.8%
Earnings Growth (YoY)
18.1%
Profit Margin
17.0%
Valuation Premium vs History
+1.9% premium
PE vs Historical
34.3 vs 32.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.9%
(market-implied from PE analysis)
1-Year Target
$347.44
(+2%)
2-Year Target
$354.04
(+4%)
3-Year Target
$360.77
(+6%)
3-Yr Target (if PE normalizes)
(PE: 34→32)
PE COMPRESSION
$340.70
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 34.3, Growth: 11.2%)
$469.10
(+38%)
Base:
(SPY PE: 20.7, Growth: 11.2%)
$283.45
(-17%)
Bear:
(PE: 17.6, Growth: 11.2%)
$240.93
(-29%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (43x PE), but valuation improves significantly next year (34x PE) as earnings recover.
Trailing PE: 43.32 | Current EPS (TTM): $7.84
Bull Case
$473.52
(+39%)
Analyst growth 26.8%, PE expands to 47.7
Base Case
$430.47
(+26%)
Market implied 26.8%, PE stable at 43.3
Bear Case
$230.92
(-32%)
Severe decline -20.0%, PE contracts to 36.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 7:00 PM ET
Data refreshes hourly during market hours. Next update: 8:00 PM
Data refreshes hourly during market hours. Next update: 8:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-02-05
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$477 | 47 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$87 | 50 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 50 HOLD |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$15 | 56 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$249 | 49 HOLD |
Advanced WST Option Strategies
Professional options setups generated by AI based on today's WST price and gamma walls.
